Cargando…
Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study
OBJECTIVES: Recent reports suggest a high prevalence of hypertension and diabetes in COVID-19 patients, but the role of cardiovascular disease (CVD) risk factors in the clinical course of COVID-19 is unknown. We evaluated the time-to-event relationship between hypertension, dyslipidaemia, diabetes a...
Autores principales: | Collard, Didier, Nurmohamed, Nick S, Kaiser, Yannick, Reeskamp, Laurens F, Dormans, Tom, Moeniralam, Hazra, Simsek, Suat, Douma, Renee, Eerens, Annet, Reidinga, Auke C, Elbers, Paul W G, Beudel, Martijn, Vogt, Liffert, Stroes, Erik S G, van den Born, Bert-Jan H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902321/ https://www.ncbi.nlm.nih.gov/pubmed/33619201 http://dx.doi.org/10.1136/bmjopen-2020-045482 |
Ejemplares similares
-
Treatment with a DPP-4 inhibitor at time of hospital admission for COVID-19 is not associated with improved clinical outcomes: data from the COVID-PREDICT cohort study in The Netherlands
por: Meijer, Rick I., et al.
Publicado: (2021) -
What is the aetiology of dysnatraemia in COVID-19 and how is this related to outcomes in patients admitted during earlier and later COVID-19 waves? A multicentre, retrospective observational study in 11 Dutch hospitals
por: de Haan, Lianne, et al.
Publicado: (2023) -
Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study
por: Nurmohamed, Nick S., et al.
Publicado: (2022) -
From evidence to practice: development of web-based Dutch lipid reference values
por: Nurmohamed, N. S., et al.
Publicado: (2021) -
Outcomes of persons with coronavirus disease 2019 in hospitals with and without standard treatment with (hydroxy)chloroquine
por: Peters, Edgar JG., et al.
Publicado: (2021)